Bristol-Myers Squibb
Bristol-Myers Squibb

BMY - Bristol-Myers Squibb • Dividends

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding DateValue (U$)Frequency
7/2/2026
0,63
Quarterly
4/2/2026
0,63
Quarterly
1/2/2026
0,63
Quarterly
10/3/2025
0,62
Quarterly
7/3/2025
0,62
Quarterly
4/4/2025
0,62
Quarterly
1/3/2025
0,62
Quarterly
10/4/2024
0,6
Quarterly
7/5/2024
0,6
Quarterly
4/4/2024
0,6
Quarterly
1/4/2024
0,6
Quarterly
10/5/2023
0,57
Quarterly
7/6/2023
0,57
Quarterly
4/6/2023
0,57
Quarterly
1/5/2023
0,57
Quarterly
10/6/2022
0,54
Quarterly
1/10

The latest dividend from BMY was $0.63 per share (ex-dividend 7/2/2026). The dividend yield over the last 12 months is 3,9%. Over the last 12 months there were 4 distributions, totalling $2.51 per share.